Scarica l'app Stockscreener
13.09
7.21%
0.88
Dopo l'orario di chiusura:
13.00
-0.09
-0.69%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$12.21
Aprire:
$12.2
Volume 24 ore:
1.51M
Relative Volume:
1.47
Capitalizzazione di mercato:
$902.26M
Reddito:
$46.02M
Utile/perdita netta:
$-70.80M
Rapporto P/E:
-7.1923
EPS:
-1.82
Flusso di cassa netto:
$-1.61M
1 W Prestazione:
+9.27%
1M Prestazione:
-8.08%
6M Prestazione:
+91.94%
1 anno Prestazione:
+11.31%
Intervallo 1D:
$11.92
$13.12
Intervallo di 1 settimana:
$11.55
$13.12
Portata 52W:
$3.91
$14.91
Eyepoint Pharmaceuticals Inc Stock (EYPT) Company Profile
Nome
Eyepoint Pharmaceuticals Inc
Settore
Industria
Telefono
617-926-5000
Indirizzo
480 PLEASANT STREET, WATERTOWN, MA
Confronta EYPT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
EYPT
Eyepoint Pharmaceuticals Inc
|
13.09 | 986.00M | 46.02M | -70.80M | -1.61M | -1.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.57 | 107.66B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
651.80 | 68.74B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
456.04 | 58.93B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
818.50 | 50.51B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
189.60 | 41.29B | 447.02M | -1.18B | -868.57M | -6.1812 |
Eyepoint Pharmaceuticals Inc Stock (EYPT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-17 | Iniziato | RBC Capital Mkts | Outperform |
| 2025-01-07 | Iniziato | Citigroup | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-28 | Iniziato | Jefferies | Buy |
| 2024-01-22 | Iniziato | JP Morgan | Overweight |
| 2023-11-02 | Iniziato | Mizuho | Buy |
| 2023-04-21 | Iniziato | Robert W. Baird | Outperform |
| 2022-07-07 | Iniziato | Chardan Capital Markets | Buy |
| 2021-03-01 | Iniziato | Cowen | Outperform |
| 2021-01-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2020-04-06 | Downgrade | B. Riley FBR | Buy → Neutral |
| 2019-11-04 | Ripresa | Laidlaw | Buy |
| 2019-09-12 | Iniziato | Guggenheim | Buy |
Mostra tutto
Eyepoint Pharmaceuticals Inc Borsa (EYPT) Ultime notizie
Should you wait for a breakout in EyePoint Pharmaceuticals Inc.Analyst Upgrade & Technical Pattern Based Signals - newser.com
Has EyePoint Pharmaceuticals Inc. formed a bullish divergenceJobs Report & Growth Oriented Trading Recommendations - newser.com
Is EyePoint Pharmaceuticals Inc. (PV3B) stock a buy before new product rollout - newser.com
Combining price and volume data for EyePoint Pharmaceuticals Inc.July 2025 Institutional & Fast Gain Stock Trading Tips - newser.com
Is EyePoint Pharmaceuticals Inc. stock ready for breakoutWeekly Stock Recap & Real-Time Market Sentiment Alerts - newser.com
EyePoint Pharmaceuticals (NASDAQ:EYPT) shareholder returns have been stellar, earning 212% in 5 years - simplywall.st
What’s next for EyePoint Pharmaceuticals Inc. stock priceWeekly Trend Recap & Daily Oversold Bounce Ideas - newser.com
Eyepoint Pharmaceuticals (EYPT) Expected to Announce Quarterly Earnings on Thursday - MarketBeat
Will EyePoint Pharmaceuticals Inc. stock split attract more investorsJuly 2025 Decliners & Fast Exit and Entry Strategy Plans - newser.com
EyePoint Pharmaceuticals Inc. stock outlook for YEARWeekly Market Report & Growth Focused Stock Pick Reports - newser.com
EyePoint Pharmaceuticals Inc Stock Analysis and ForecastCandlestick Pattern Analysis & Consistently Superior Profits - earlytimes.in
With 57% institutional ownership, EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) is a favorite amongst the big guns - Yahoo Finance
Will EyePoint Pharmaceuticals Inc. stock outperform growth indexesTrade Risk Report & Free High Return Stock Watch Alerts - newser.com
EyePoint Pharmaceuticals to Host Conference Call for Q3 2025 Financial Results on November 5, 2025 - Quiver Quantitative
EyePoint to Report Third Quarter 2025 Financial Results on November 5, 2025 - The Manila Times
EyePoint Pharmaceuticals (NASDAQ: EYPT) sets 8:30 a.m. ET call to discuss Q3 results - Stock Titan
Will EyePoint Pharmaceuticals Inc. stock see insider buyingJuly 2025 Momentum & Weekly High Momentum Picks - fcp.pa.gov.br
Is EyePoint Pharmaceuticals Inc. stock recession proof2025 Risk Factors & Verified Short-Term Trading Plans - fcp.pa.gov.br
Is EyePoint Pharmaceuticals Inc. stock a safe buy before earningsWeekly Stock Recap & Smart Money Movement Tracker - fcp.pa.gov.br
EyePoint Pharmaceuticals Completes US$150 Million Follow-On Equity Offering - Global Legal Chronicle
What drives EyePoint Pharmaceuticals Inc stock priceDouble Top/Bottom Patterns & Maximize Gains Professionally - earlytimes.in
Eyepoint Pharmaceuticals Inc Azioni (EYPT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.62%
0.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):